SG11201903097UA - Antiseptic composition comprising polyvinylpyrrolidone and unithiol and use of the composition - Google Patents
Antiseptic composition comprising polyvinylpyrrolidone and unithiol and use of the compositionInfo
- Publication number
- SG11201903097UA SG11201903097UA SG11201903097UA SG11201903097UA SG11201903097UA SG 11201903097U A SG11201903097U A SG 11201903097UA SG 11201903097U A SG11201903097U A SG 11201903097UA SG 11201903097U A SG11201903097U A SG 11201903097UA SG 11201903097U A SG11201903097U A SG 11201903097UA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- composition
- moscow
- antiseptic
- pct
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 9
- 230000002421 anti-septic effect Effects 0.000 title abstract 5
- JLVSRWOIZZXQAD-UHFFFAOYSA-N 2,3-disulfanylpropane-1-sulfonic acid Chemical compound OS(=O)(=O)CC(S)CS JLVSRWOIZZXQAD-UHFFFAOYSA-N 0.000 title abstract 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 title abstract 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 title abstract 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 title abstract 3
- 229960003196 unithiol Drugs 0.000 title abstract 3
- 206010052428 Wound Diseases 0.000 abstract 5
- 208000027418 Wounds and injury Diseases 0.000 abstract 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 230000003444 anaesthetic effect Effects 0.000 abstract 1
- 229940035674 anesthetics Drugs 0.000 abstract 1
- 230000001147 anti-toxic effect Effects 0.000 abstract 1
- 229940064004 antiseptic throat preparations Drugs 0.000 abstract 1
- 229960001760 dimethyl sulfoxide Drugs 0.000 abstract 1
- 239000003193 general anesthetic agent Substances 0.000 abstract 1
- 239000003589 local anesthetic agent Substances 0.000 abstract 1
- 229960005015 local anesthetics Drugs 0.000 abstract 1
- 230000008520 organization Effects 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 102220240796 rs553605556 Human genes 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
- A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
- A61K31/79—Polymers of vinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/38—Silver; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Emergency Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Materials Engineering (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2017106061A RU2649785C1 (ru) | 2017-02-22 | 2017-02-22 | Антисептическая композиция, содержащая поливинилпирролидон и унитиол, применение такой композиции и способ обработки ран с ее использованием |
| PCT/RU2017/000905 WO2018156051A1 (en) | 2017-02-22 | 2017-12-14 | Antiseptic composition comprising polyvinylpyrrolidone and unithiol and use of the composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201903097UA true SG11201903097UA (en) | 2019-09-27 |
Family
ID=61094570
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201903097UA SG11201903097UA (en) | 2017-02-22 | 2017-12-14 | Antiseptic composition comprising polyvinylpyrrolidone and unithiol and use of the composition |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US11045551B2 (ru) |
| EP (1) | EP3585399B1 (ru) |
| JP (1) | JP6690816B2 (ru) |
| KR (1) | KR102096257B1 (ru) |
| CN (1) | CN110198721B (ru) |
| AU (1) | AU2017400650B2 (ru) |
| BR (1) | BR112019016560A2 (ru) |
| CA (1) | CA3054002C (ru) |
| CL (1) | CL2019002259A1 (ru) |
| EA (1) | EA037319B1 (ru) |
| GE (1) | GEP20207136B (ru) |
| MA (1) | MA46159B1 (ru) |
| MX (1) | MX2019009761A (ru) |
| PL (1) | PL3585399T3 (ru) |
| RU (1) | RU2649785C1 (ru) |
| SG (1) | SG11201903097UA (ru) |
| UA (1) | UA121949C2 (ru) |
| WO (1) | WO2018156051A1 (ru) |
| ZA (1) | ZA201905343B (ru) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2713884C1 (ru) * | 2018-12-18 | 2020-02-10 | Екатерина Николаевна Мехоношина | Жидкая композиция для получения спрея для формирования антимикробной раневой повязки при микротравмах кожи |
| PL445149A1 (pl) * | 2023-06-06 | 2024-06-17 | Uniwersytet Medyczny W Lublinie | Sposób wytwarzania wkładu opatrunkowego na bazie kurdlanu do zastosowań medycznych |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2739922A (en) | 1952-03-13 | 1956-03-27 | Herman A Shelanski | Mixtures of polymeric n-vinyl pyrrolidone and halogens |
| US3761590A (en) | 1970-05-18 | 1973-09-25 | Research Corp | Silver sulfadiazine used in the treatment of burns |
| GB2148901A (en) | 1983-10-04 | 1985-06-05 | Johnson & Johnson | Protein/polysaccharide complexes |
| RU2062113C1 (ru) * | 1993-10-19 | 1996-06-20 | Владимир Валентинович Рыльцев | Способ получения перевязочных материалов |
| RU2088234C1 (ru) | 1994-11-25 | 1997-08-27 | Институт высокомолекулярных соединений РАН | Водорастворимая бактерицидная композиция и способ ее получения |
| UA13954C2 (ru) * | 1996-06-13 | 2001-05-15 | Державний Науковий Центр Лікарських Засобів | Антибактериальное средство для местного применения |
| RU2185155C2 (ru) | 2000-04-27 | 2002-07-20 | Кривошеин Юрий Семенович | Клей антисептический ранозаживляющий |
| US6828308B2 (en) * | 2000-07-28 | 2004-12-07 | Sinclair Pharmaceuticals, Ltd. | Compositions and methods for the treatment or prevention of inflammation |
| RU2175549C1 (ru) * | 2000-10-26 | 2001-11-10 | Закрытое акционерное общество "ТОП-ВЕТ" | Ранозаживляющий лекарственный препарат "зоодерм" |
| US10117812B2 (en) * | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
| RU2284824C1 (ru) * | 2005-03-18 | 2006-10-10 | Общество с ограниченной ответственностью "Сирена" | Клей хирургический антисептический "аргакол" |
| WO2006121219A1 (ja) * | 2005-05-13 | 2006-11-16 | Osaka University | 上皮−間葉転換制御剤 |
| US8377468B2 (en) * | 2006-08-28 | 2013-02-19 | Rexaderm, Inc. | Dry wound dressing and drug delivery system |
| RU2403921C1 (ru) * | 2009-04-01 | 2010-11-20 | Государственное образовательное учреждение высшего профессионального образования "Дальневосточный государственный медицинский университет Федерального агентства по здравоохранению и социальному развитию" | Способ комбинированного лечения ограниченной склеродермии с применением локального трансдермального ферментативного электростатического воздействия |
| RU2404781C1 (ru) * | 2009-07-23 | 2010-11-27 | Институт элементоорганических соединений РАН (ИНЭОС РАН) | Композиция в качестве бактерицидного средства, способ получения материала на ее основе и макропористый бактерицидный материал на основе данной композиции |
| CN103505470A (zh) * | 2012-06-22 | 2014-01-15 | 江苏胜意药业有限公司 | 一种聚维酮碘溶液的生产方法 |
| AU2015212312A1 (en) * | 2014-01-29 | 2016-08-18 | Vyome Therapeutics Limited | Treatments for resistant acne |
| RU2545915C1 (ru) * | 2014-02-14 | 2015-04-10 | Олег Васильевич Рубальский | Способ лечения хронического болевого синдрома |
| RU2545798C1 (ru) * | 2014-03-24 | 2015-04-10 | Закрытое акционерное общество "ФИРН М" (ЗАО "ФИРН М") | Фармацевтическая композиция для оказания первой медицинской помощи при ожогах различной этиологии, площади и глубины в форме спрея, геля, аэрозоля |
| RU2603490C1 (ru) * | 2015-11-30 | 2016-11-27 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации | Средство для лечения гнойно-воспалительных процессов мягких тканей и слизистых оболочек |
| RU2605343C1 (ru) * | 2015-11-30 | 2016-12-20 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации | Средство для лечения гнойно-воспалительных процессов мягких тканей и слизистых оболочек |
-
2017
- 2017-02-22 RU RU2017106061A patent/RU2649785C1/ru active
- 2017-12-14 GE GEAP201715119A patent/GEP20207136B/en unknown
- 2017-12-14 BR BR112019016560-6A patent/BR112019016560A2/pt unknown
- 2017-12-14 JP JP2019535309A patent/JP6690816B2/ja active Active
- 2017-12-14 US US16/480,536 patent/US11045551B2/en active Active
- 2017-12-14 KR KR1020197023386A patent/KR102096257B1/ko active IP Right Grant
- 2017-12-14 MA MA46159A patent/MA46159B1/fr unknown
- 2017-12-14 EP EP17836069.9A patent/EP3585399B1/en active Active
- 2017-12-14 EA EA201991275A patent/EA037319B1/ru unknown
- 2017-12-14 CA CA3054002A patent/CA3054002C/en active Active
- 2017-12-14 UA UAA201907164A patent/UA121949C2/uk unknown
- 2017-12-14 PL PL17836069T patent/PL3585399T3/pl unknown
- 2017-12-14 CN CN201780084018.6A patent/CN110198721B/zh active Active
- 2017-12-14 SG SG11201903097UA patent/SG11201903097UA/en unknown
- 2017-12-14 AU AU2017400650A patent/AU2017400650B2/en not_active Ceased
- 2017-12-14 WO PCT/RU2017/000905 patent/WO2018156051A1/en active Application Filing
- 2017-12-14 MX MX2019009761A patent/MX2019009761A/es unknown
-
2019
- 2019-08-09 CL CL2019002259A patent/CL2019002259A1/es unknown
- 2019-08-13 ZA ZA2019/05343A patent/ZA201905343B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR102096257B1 (ko) | 2020-04-06 |
| US20190381176A1 (en) | 2019-12-19 |
| EA037319B1 (ru) | 2021-03-11 |
| CL2019002259A1 (es) | 2020-01-03 |
| EA201991275A1 (ru) | 2019-11-29 |
| CN110198721B (zh) | 2022-06-07 |
| KR20190099338A (ko) | 2019-08-26 |
| JP6690816B2 (ja) | 2020-04-28 |
| WO2018156051A1 (en) | 2018-08-30 |
| AU2017400650B2 (en) | 2019-09-26 |
| RU2649785C1 (ru) | 2018-04-04 |
| BR112019016560A2 (pt) | 2020-03-31 |
| MA46159A1 (fr) | 2021-04-30 |
| CA3054002C (en) | 2021-07-20 |
| AU2017400650A1 (en) | 2019-07-18 |
| MX2019009761A (es) | 2019-10-07 |
| GEP20207136B (en) | 2020-07-27 |
| US11045551B2 (en) | 2021-06-29 |
| PL3585399T3 (pl) | 2022-05-30 |
| MA46159B1 (fr) | 2022-04-29 |
| CA3054002A1 (en) | 2018-08-30 |
| EP3585399A1 (en) | 2020-01-01 |
| EP3585399B1 (en) | 2022-02-09 |
| ZA201905343B (en) | 2021-08-25 |
| UA121949C2 (uk) | 2020-08-10 |
| JP2020506164A (ja) | 2020-02-27 |
| CN110198721A (zh) | 2019-09-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201804312RA (en) | Microbubble-chemotherapeutic agent complex for sonodynamic therapy | |
| SG11201906297QA (en) | Nucleic acids encoding crispr-associated proteins and uses thereof | |
| SG11201804373VA (en) | Compositions and methods for immunooncology | |
| SG11201808222RA (en) | Methods of treatment of cholestatic diseases | |
| SG11201901534VA (en) | Combination therapy with controlled-release cnp agonists | |
| SG11202000266VA (en) | Quinoline derivatives for treating infections with helminths | |
| SG11201810280YA (en) | Spiro-lactam nmda receptor modulators and uses thereof | |
| SG11201806868TA (en) | Compositions and methods for protecting against airborne pathogens and irritants | |
| SG11201900558RA (en) | Spiro-lactam nmda receptor modulators and uses thereof | |
| SG11201900546UA (en) | Spiro-lactam and bis-spiro-lactam nmda receptor modulators and uses thereof | |
| SG11201900551WA (en) | Spiro-lactam nmda receptor modulators and uses thereof | |
| SG11201811209QA (en) | Oral gastroretentive formulations and uses thereof | |
| SG11201906222WA (en) | Jak1 selective inhibitors | |
| SG11201806968RA (en) | Novel acid addition salt of 1-(5-(2,4-difluorophenyl)-1-((3- fluorophenyl)sulfonyl)-4-methoxy-1h-pyrrol-3-yl)-n- methylmethanamine | |
| SG11201906436VA (en) | Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same | |
| SG11201809882XA (en) | Pharmaceutical combinations for treating cancer | |
| SG11201901063SA (en) | Therapeutic agents for neurodegenerative diseases | |
| SG11201805001UA (en) | Method of treating influenza a | |
| SG11201903061YA (en) | Combination treatments comprising administration of imidazopyrazinones | |
| SG11201804587QA (en) | Isoindole compounds | |
| SG11201901048VA (en) | Pharmaceutical compositions and uses directed to lysosomal storage disorders | |
| SG11201805649UA (en) | Therapeutic anti-cd9 antibody | |
| SG11201908691PA (en) | Compounds and methods for the treatment of parasitic diseases | |
| SG11201901249YA (en) | Aza-indazole compounds for use in tendon and/or ligament injuries | |
| SG11201908065YA (en) | Deuterated imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer |